Androgen activates β-catenin signaling in bladder cancer cells

Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma

(2012) H. Miyamoto et al.   CURRENT CANCER DRUG TARGETS

The Role of the Androgen Receptor in the Development and Progression of Bladder Cancer

(2012) Y. Li et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer

(2011) Hiroshi Hirata et al.   CARCINOGENESIS

Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells

(2011) Y. Zheng et al.   ENDOCRINE-RELATED CANCER

Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: A potential mechanism of androgen-induced bladder carcinogenesis

(2011) Koji Izumi et al.   MOLECULAR CARCINOGENESIS

Androgen Receptor Is a Potential Therapeutic Target for Bladder Cancer

(2010) Ji-Tao Wu et al.   UROLOGY

Epstein-Barr Virus Latent Membrane Protein-1 Effects on Junctional Plakoglobin and Induction of a Cadherin Switch

(2009) K. H.Y Shair et al.   CANCER RESEARCH

Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens

(2009) K. K. Waltering et al.   CANCER RESEARCH

Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1

(2009) Xiaochen Tian et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells

(2009) Y. Tang et al.   MOLECULAR CANCER THERAPEUTICS

Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone

(2009) J.P. Michiel Sedelaar et al.   PROSTATE

Crosstalk between the Androgen Receptor and  -Catenin in Castrate-Resistant Prostate Cancer

(2008) G. Wang et al.   CANCER RESEARCH

Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder

(2008) Stephen A Boorjian et al.   ENDOCRINE-RELATED CANCER

Regulation of Myogenic Differentiation by Androgens: Cross Talk between Androgen Receptor/ β-Catenin and Follistatin/Transforming Growth Factor-β Signaling Pathways

(2008) Rajan Singh et al.   ENDOCRINOLOGY

Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: Evidence for Wnt pathway implication

(2008) Efstathios Kastritis et al.   INTERNATIONAL JOURNAL OF CANCER

Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1

(2008) Aimee M Johnson et al.   BMC Urology

The first five years of the Wnt targetome

(2007) Annica Vlad et al.   CELLULAR SIGNALLING